AIM ImmunoTech News - June 15, 2026
AIM ImmunoTech Regains Compliance with NYSE American Listing Standards
AIM ImmunoTech announced it has regained compliance with the NYSE American's continued listing standards after resolving a stockholder equity deficiency. The...
🔴 AIM ImmunoTech Inc is trading 84.27% down today after regaining NYSE American compliance and disclosing new financing
AIM ImmunoTech Inc is trading at $0.43 (-84.27%) after regaining NYSE American compliance with stockholders’ equity requirements. • The exchange removed the...
🟢 AIM ImmunoTech Inc is trading 14.6% up today after regaining NYSE American compliance
AIM ImmunoTech Inc is trading 14.6% up at $0.47 in pre-market sessions. • The company announced today, June 15, 2026, that it has regained compliance with NYSE...